VVN-461

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameVVN-461
Drug Alias NameVVN-461VVN461eVVN-461-eVVN461LD
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK1 inhibitorsTyrosine-protein kinase 2 inhibitors
TargetsTyrosine-protein kinase JAK1Tyrosine-protein kinase 2
Therapy Area/IndicationsPostoperative inflammationInflammationUveitis, Anterior +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesVivaVision Biotech Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesVivaVision Biotech Inc
Inactive CompaniesN/A
Active IndicationsPostoperative inflammationInflammationUveitis, Anterior +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A